HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

Executive Summary

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

You may also be interested in...

Prenatal vitamin E and asthma

Children are more likely to develop wheezing and asthma by age 5, if mothers do not have a sufficient intake of vitamin E during pregnancy, according to a study published in the September American Journal of Respiratory & Critical Care Medicine. The vitamin E levels and respiratory status of 1,253 mothers and children were assessed over a five-year period, Graham Devereux, MD, PhD, et al., Department of Environmental & Occupational Medicine, University of Aberdeen, UK, state. In a previous study, the researchers assessed vitamin E levels in 1,856 mothers at 12 weeks gestation and obtained symptom questionnaire data from 1,253 children. In light of the new findings, children born to mothers whose intakes of vitamin E ranked in the lowest quintile were five times more likely to manifest early persistent asthma than mothers with vitamin E intakes in the highest quintile, Devereux et al. state. The researchers suggest the relationship between prenatal vitamin E intake and children's rates of asthma "warrants further investigation," adding that vitamin E supplementation in adults who have asthma has not shown to provide clinical benefits...

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Guidance Opening Sanitizer Production Stirs Firms Including Anheuser-Busch, Dow, Kodak

Dow Chemical, Anheuser-Busch and Kodak designate manufacturing for hand sanitizers and donate products to fight COVID-19. Dow is making up to 15 tons of sanitizer a day while Kodak donates formulas to New York's “NYS Clean” sanitizer distribution program.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts